Cell and Gene Therapy 01/10/2018 [INTERVIEW] An Academic Perspective on Cell Therapy, Trial Design... An interview with Dr David Courtman of the Ottawa Hospital, the University of Ottawa and Northern Therapeutics
Cell and Gene Therapy 20/09/2018 60 seconds with...Detlev Parow, DAK-Gesundheit A Payer’s Perspective on CAR-T Pricing and Reimbursement
Cell and Gene Therapy 12/09/2018 The Evolution of Advanced Therapies: A 200-Year History A guide to 200 years of milestones, achievements and innovations that have led to today's advanced therapies industry. What will we see over the...
Cell and Gene Therapy 06/09/2018 We’re answering this year’s question with a firm “maybe!” A guest blog from Stacey Johnson, Director, Communications and Marketing at CCRM and Phacilitate:Exchange editorial board member
Cell and Gene Therapy 31/08/2018 WEBINAR: Avoid Tripping at the Last Mile Your therapy is cryopreserved and ready to change a patient's life. Is the cryogenic ecosystem in place to ensure you do not trip at the last...
Cell and Gene Therapy 14/08/2018 Preparing for Commercialisation with the Right CDMO An interview with J. Kelly Ganjei, CEO and Chairman of the Board, Cognate BioServices, Inc
Cell and Gene Therapy 01/08/2018 Building Manufacturing Infrastructure for Cell and Gene Therapies The production shortfall for cell therapies and viral vectors could have a devastating effect on the growth and success of the industry but...
Cell and Gene Therapy 31/07/2018 The Importance of Durability for Anticancer Cell Therapies Cenk Sumen, Director at Thermo Fisher discuss durability of anticancer therapies and its importance in relation to pricing and reimbursement...
Cell and Gene Therapy 24/07/2018 Raman Spectroscopy: A New Analytical Technique to Ensure the... As we see more cell and gene therapies gaining market authorisation, attention is turning to the bioprocesses used for their manufacture,...
Cell and Gene Therapy 05/07/2018 Video: Gaining a Competitive Edge Through Effective Process Design... Episode three in the top tips series is with Ohad Karnieli, CEO and Co-founder of ATVIO Biotechnology. Ohad gives his unequivocal views on the...
Cell and Gene Therapy 01/06/2018 How do you Solve a Problem Like Cell Therapy Manufacturing? The Automation SIG is a platform to debate, collaborate and work towards genuine solutions for the new paradigm of manufacturing needed...
Cell and Gene Therapy 23/05/2018 VIDEO: The Small Biotech's Guide to Managing Partnerships The small biotech's guide to identifying, setting up and successfully managing partnerships with Susan Nichols, CEO Falcon Therapeutics
Cell and Gene Therapy 16/05/2018 VIDEO: Has Japan’s Regenerative Medicine Experiment Paid Off? The first episode in Phacilitate:Exchange's Top Tips series is brought to you by Lee Buckler, President and CEO of RepliCel Life Sciences...
Cell and Gene Therapy 03/05/2018 VIDEO: Automation is Nothing Without Collaboration This collaborative panel, filmed at Phacilitate Leaders World 2018 in Miami, reviews the 2017 Automation SIG. Experts from CGTC, Novartis,...
Cell and Gene Therapy 03/04/2018 The UK is a Leader in Preclinical Cell and Gene Therapy Research The UK has a rich and diverse range of preclinical research and is setting the foundations for the therapies of the future. The CGT Catapult’s...
